Header Logo

Connection

MARINA KONOPLEVA to Glucose Transporter Type 1

Back to Details
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Glucose Transporter Type 1.
MARINA KONOPLEVA
Connection Strength
0.071
Glucose Transporter Type 1
  1. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood. 2007 Apr 15; 109(8):3509-12.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.